| scholarly article | Q13442814 |
| P2093 | author name string | Bernard W Futscher | |
| Christina J Kim | |||
| Marc M Oshiro | |||
| Petr Novak | |||
| George S Watts | |||
| Taylor Jensen | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| Epigenetic silencing of DSC3 is a common event in human breast cancer | Q21195245 | ||
| A striking organization of a large family of human neural cadherin-like cell adhesion genes | Q22010159 | ||
| Characterization of the GAGE genes that are expressed in various human cancers and in normal testis | Q22010231 | ||
| Compromised HOXA5 function can limit p53 expression in human breast tumours | Q22254441 | ||
| A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers | Q24317542 | ||
| Global and Hox-specific roles for the MLL1 methyltransferase | Q24529562 | ||
| Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry | Q24536837 | ||
| High sensitivity mapping of methylated cytosines | Q24630600 | ||
| Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome | Q24648552 | ||
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Q24672969 | ||
| BLAT—The BLAST-Like Alignment Tool | Q24682492 | ||
| Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites | Q24682593 | ||
| Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene | Q28145754 | ||
| CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus | Q28145756 | ||
| Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity | Q28215031 | ||
| The epigenomics of cancer | Q28289975 | ||
| Boundaries between chromosomal domains of X inactivation and escape bind CTCF and lack CpG methylation during early development | Q28304098 | ||
| Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells | Q29618090 | ||
| Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 | ||
| Altered Hox expression and segmental identity in Mll-mutant mice | Q29620391 | ||
| Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays | Q33205674 | ||
| Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements | Q33298863 | ||
| Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 | ||
| Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. | Q34361939 | ||
| Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma | Q34453650 | ||
| Epigenetic inactivation of the HOXA gene cluster in breast cancer | Q34580018 | ||
| Breast cancer prevention trials using retinoids | Q35572432 | ||
| Abnormal regional hypermethylation in cancer cells | Q35777785 | ||
| The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy | Q35847845 | ||
| DNA hypomethylation is prevalent even in low-grade breast cancers | Q35946741 | ||
| High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer | Q36423456 | ||
| Epigenetic remodeling during arsenical-induced malignant transformation. | Q36838009 | ||
| Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer | Q40073646 | ||
| Regional copy number-independent deregulation of transcription in cancer | Q40209266 | ||
| Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers | Q43578083 | ||
| Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. | Q43890956 | ||
| p53 mutations in breast cancer | Q44007369 | ||
| Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. | Q48052612 | ||
| DNA motifs associated with aberrant CpG island methylation | Q51949819 | ||
| Retinoic acid and homeobox gene regulation | Q52215432 | ||
| DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter | Q52558910 | ||
| Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. | Q53346861 | ||
| Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. | Q53938536 | ||
| Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours | Q54573965 | ||
| A distribution free summarization method for Affymetrix GeneChip(R) arrays | Q56880035 | ||
| Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
| Hypomethylation of pericentromeric DNA in breast adenocarcinomas | Q77132854 | ||
| Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF | Q79961217 | ||
| Identification of 20 genes aberrantly methylated in human breast cancers | Q81629206 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 8616-8625 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Agglomerative epigenetic aberrations are a common event in human breast cancer | |
| P478 | volume | 68 |
| Q34462001 | A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression |
| Q82891679 | A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype |
| Q47356569 | A suite of DNA methylation markers that can detect most common human cancers. |
| Q38905879 | Aberrant expression and functions of protocadherins in human malignant tumors |
| Q36402756 | Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation |
| Q38829665 | Alterations in Three-Dimensional Organization of the Cancer Genome and Epigenome. |
| Q36920160 | Antisense Transcript Long Noncoding RNA (lncRNA) HOTAIR is Transcriptionally Induced by Estradiol |
| Q37440422 | Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells |
| Q35832742 | Associations with early-life socio-economic position in adult DNA methylation |
| Q38179961 | Beyond E-cadherin: roles of other cadherin superfamily members in cancer |
| Q33649722 | Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. |
| Q35136051 | Breast cancer methylomes establish an epigenomic foundation for metastasis |
| Q27314001 | Broad Epigenetic Signature of Maternal Care in the Brain of Adult Rats |
| Q34533607 | Cell-type specific DNA methylation patterns define human breast cellular identity |
| Q37622144 | Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. |
| Q26798258 | Circadian disruption and breast cancer: an epigenetic link? |
| Q34743908 | Clinical potentials of methylator phenotype in stage 4 high-risk neuroblastoma: an open challenge. |
| Q38088475 | Clustered Protocadherins and Neuronal Diversity |
| Q91750876 | Clustered protocadherins methylation alterations in cancer |
| Q27025145 | Common gene pathways and families altered by DNA methylation in breast and prostate cancers |
| Q48215153 | Comparative analysis of DNA methylation patterns of equine sarcoid and healthy skin samples. |
| Q34680105 | Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity |
| Q96642228 | Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions |
| Q36895363 | Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells |
| Q38041524 | DNA Hypomethylation and Activation of Germline-Specific Genes in Cancer |
| Q33862334 | DNA hypomethylation in cancer cells |
| Q83528971 | DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis |
| Q99592145 | DNA methylation of FKBP5 in South African women: associations with obesity and insulin resistance |
| Q48017834 | DNA methylation of extracellular matrix remodeling genes in children exposed to arsenic |
| Q53830978 | DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features. |
| Q34412268 | DNA methylation profiles of airway epithelial cells and PBMCs from healthy, atopic and asthmatic children |
| Q33708624 | DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status |
| Q38261602 | DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment |
| Q38498575 | Differential DNA methylation patterns define status epilepticus and epileptic tolerance. |
| Q51275940 | Disruption of the 3D cancer genome blueprint. |
| Q35051585 | Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis |
| Q35953777 | Estrogen-induced chromatin decondensation and nuclear re-organization linked to regional epigenetic regulation in breast cancer |
| Q33736481 | Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation |
| Q24611593 | Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines |
| Q30945124 | Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor |
| Q37138680 | Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm |
| Q35986705 | Functional test of PCDHB11, the most human-specific neuronal surface protein |
| Q37600904 | Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer |
| Q98771198 | Gene Co-expression Is Distance-Dependent in Breast Cancer |
| Q58321447 | Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions |
| Q33687781 | Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer |
| Q35694382 | Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer |
| Q35032304 | Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV |
| Q30666001 | HMCan: a method for detecting chromatin modifications in cancer samples using ChIP-seq data. |
| Q41854729 | HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. |
| Q92035657 | Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study |
| Q34181789 | Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis |
| Q36759572 | Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells |
| Q24607308 | Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis |
| Q41134275 | Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells. |
| Q40492521 | Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. |
| Q42065079 | Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions |
| Q84153203 | Methylated promoters of genes encoding protocadherins as a new cancer biomarker family |
| Q27332414 | Promoter methylation of glucocorticoid receptor gene is associated with subclinical atherosclerosis: A monozygotic twin study |
| Q97644181 | Protocadherins at the Crossroad of Signaling Pathways |
| Q33687763 | RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer |
| Q36265886 | Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer |
| Q27011533 | Regulation of mammary epithelial cell homeostasis by lncRNAs |
| Q37229718 | Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. |
| Q37772356 | The epigenetics of breast cancer |
| Q36959187 | Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations. |
| Q36126987 | Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching |
| Q35052996 | Understanding the connection between epigenetic DNA methylation and nucleosome positioning from computer simulations |
| Q21133750 | miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer |
Search more.